Regenerative Research Blend
GHK-Cu 50mg + BPC-157 10mg + TB-500 10mg + KPV 10mg
A four-component research blend designed for investigation of complementary pathways associated with tissue remodeling, collagen and skin biology, cellular repair, inflammatory signaling, and recovery mechanisms. Combining GHK-Cu, BPC-157, TB-500, and KPV provides researchers with a comprehensive formulation for studying regenerative and cellular-response pathways.
For research purposes only.
Regenerative Research Blend
GHK-Cu 50mg + BPC-157 10mg + TB-500 10mg + KPV 10mg
A four-component research blend designed for investigation of complementary pathways associated with tissue remodeling, collagen and skin biology, cellular repair, inflammatory signaling, and recovery mechanisms. Combining GHK-Cu, BPC-157, TB-500, and KPV provides researchers with a comprehensive formulation for studying regenerative and cellular-response pathways.
For research purposes only.
| Type | Synthetic compound |
|---|---|
| Category | Research Compound |
| Purity | ≥99% |
| Form | Lyophilized powder |
-20°C · 24+ months
2–8°C · ~30 days
Third-party tested for purity and quality.
| Variant | GLP3-RT 10mg |
|---|---|
| Lot # | REF0001 |
| Labeled | 20mg |
| Actual | 22.61mg |
| Tested | APR 15, 2026 |
Triple–Hormone-Receptor Agonist GLP-3 (RT) for Obesity — A Phase 2 Trial
2023
DOI: 10.1056/NEJMoa2301972
· Jastreboff AM, et al.
Triple–Hormone-Receptor Agonist GLP-3 (RT) for Obesity — A Phase 2 Trial
2023
DOI: 10.1056/NEJMoa2301972
· Jastreboff AM, et al.
Triple–Hormone-Receptor Agonist GLP-3 (RT) for Obesity — A Phase 2 Trial
2023
DOI: 10.1056/NEJMoa2301972
· Jastreboff AM, et al.
on orders over $200
plain and unbranded packaging
256-bit SSL
Not a researcher? Exit
